April 3, 2014 H3 Biomedicine’s First Lead Candidate Program Targets Novel Genetic Mutations Involved in Multiple Cancers Company to Present Data on SF3B1 Program at a Symposium During the American Association for Cancer Research Annual Meeting 2014 Read More